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This paper describes the application of static headspace gas chromatography in determining benzene in 
urine. The method was analytically validated for sensitivity (DL=42 ng/l), repeatability (RSD=3% and 4%), 
and accuracy (71%), and was applied in measuring urine benzene in nonsmokers (N=14) and smokers 
(N=18). All urine samples had measurable benzene concentrations. The method proved sensitive enough 
to establish a significant statistical difference (P<0.000614) in urine benzene concentrations between 
smokers (mean=760; range =181–1869 ng/l) and nonsmokers (mean=214; range=61–515 ng/l).
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Benzene is a haematotoxic substance that can 
induce acute myeloid leukaemia in occupational 
exposure, and has been classified as a carcinogen 
in humans by the International Agency for Research 
on Cancer (IARC) (1). General population is more or 
less permanently exposed to this widespread pollutant 
(2). Nonsmokers are largely exposed to benzene from 
car exhausts or petrol vapour. The main source of 
benzene exposure for smokers is the cigarette smoke. 
Although the health risk of environmental benzene 
exposure seems low, the significance of a lifetime 
absorption of low levels of benzene, including the 
potential effects of interaction with other substances 
in vivo, is unknown. Individual exposure to benzene 
can be evaluated by the measurement of benzene in 
biological samples, that is, by biomonitoring. Benzene 
is usually analysed in blood or exhaled breath (3). The 
quantitation of benzene concentration in urine has 
recently become possible thanks to the development 
of new analytical techniques with high sensitivity (4). 
These are required because less than 0.1% of the total 
uptake of benzene is excreted unmetabolised in urine 
(2). Urinary benzene is a promising biomarker because 
it is specific and reflects air exposure even at low levels 
(5). Generally, benzene analysis has involved either 
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static (6, 7) or dynamic (8, 9) headspace sampling, 
followed by gas chromatographic separation and 
photoionisation (6, 7) or flame ionisation detection 
(7, 9). Headspace sampling is an indirect method 
for determining volatile analytes in a liquid or solid 
sample in the vapour phase. If the vapour phase has 
been equilibrated with the sample, this technique is 
referred to as static. If the vapour phase has been 
purged from the sample (and there is no equilibrium) 
and subsequently adsorbed on a cryogenic trap or 
microfibre and thermally desorbed, this technique is 
called dynamic.
This paper describes static headspace gas 
chromatography applied to determine urine benzene 
concentrations in nonsmokers and smokers.
MATERIALS, METHOD, AND SUBJECTS
Materials
Benzene, methanol and n–hexane were analytical–
grade–purity products of Merck (Darmstadt, Germany). 
The standard reference material for benzene MISA 
group 17 non–halogenated mix (Cat. no. 4–8133), 
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containing 2000 µg/ml of benzene in methanol, was 
purchased from Supelco (Bellefonte, PA, USA). Six 
millilitre headspace vials with aluminium crimp caps 
with liners, hand crimper, and decapper were obtained 
from Varian (Harbor City, USA).
Standard preparation
The benzene stock solution was prepared by 
diluting 3 µl (2.64 mg) of benzene to a volume of 10 
ml of methanol. Forty µl of the stock solution was 
further diluted with methanol to 2 ml and labelled 
as standard A. Working standards were prepared 
by spiking known amounts of the standard A into 
deionised, boiled, and cooled water. Hundred µl of 
working standards were added to 1.9 ml of blank 
urine. Since almost every urine sample has a 
measurable benzene concentration, blank urine was 
prepared by purging it with nitrogen for 30 min at 
40 °C. The final concentrations of benzene in urine 
ranged from 148 to 3549 ng/l. The stock solution 
and the standard A were kept at –20 °C, and working 
standards were freshly prepared every day.
Gas chromatographic conditions
To measure benzene, we used a Varian 3800 gas 
chromatograph with photoionisation detector (PID) 
and a 30 m, 0.53 mm I.D., 3.0 µm film thickness 
VOCOL (6% cyanopropylphenyl 94% dimethyl 
polysiloxane) capillary column. Helium was the 
carrier gas (139.5 kPa) with the flow of 40.3 ml/min, 
and hydrogen was the sweep gas with the flow of 30 
ml/min. The initial oven temperature was 50 °C for 
2.5 min, then it gradually increased 10 °C/min until 
it reached and remained 180 °C for four min. The 
injector and detector temperatures were 120 °C and 
180 °C, respectively.
Subjects
Benzene was determined in 32 urine samples 
from healthy adults without any known occupational 
benzene exposure. The subjects were smokers (N=18) 
and nonsmokers (N=14).
Urine sampling
The first urine samples were collected in the 
morning in clean 80–ml bottles, completely filled to 
avoid loss to the headspace. The bottles were kept 
in a refrigerator (4 °C). As a rule, the urine samples 
were analysed the same day when collected. The 
measurements included the creatinine content in 
all samples.
Urine analysis
Two ml of urine were pipetted into a 6–ml headspace 
vial and immediately sealed with an aluminium crimp 
cap. The vials were gently stirred and incubated at 60 
°C for 60 min in a thermostat. After achieving partial 
pressure equilibration, 0.5 ml of the headspace air 
was injected into the gas chromatograph.
RESULTS AND DISCUSSION
One of the main advantages of the headspace 
technique is the elimination of interference from 
the biological matrix. Static headspace analysis is 
based on an equilibrium between two phases, the 
liquid (or solid) phase – that is, the sample – and the 
gas phase above it. After equilibration, the gas phase 
(vapour), which is richer in volatile compounds than 
the liquid, is analysed by gas chromatography and 
the initial liquid phase concentration is determined 
by the measurement of the equilibrated vapour 
phase concentration. Therefore, it is evident that the 
incubation temperature and the equilibration time 
are very important parameters in static headspace 
analysis. Figure 1 shows the benzene peak area 
at the incubation temperatures of 60, 70, and 80 
°C. As the incubation temperature increased, so 
did the peak area. The reason is that the partition 
coefficient decreases with the increased temperature, 
which means that the sensitivity of headspace gas 
chromatography is better at elevated temperatures 
(10). Although the maximal response was at 80 °C 
(Figure 1, equation 3) the intercepts of the calibration 
curves at 70 and 80 o C were too high, which could 
yield wrong results at low benzene concentrations. 
Furthermore, at higher incubation temperatures, 
vapour may condensate before being injected onto 
the column. This is why we chose the incubation 
temperature of 60 °C for the analyses. Headspace 
benzene reached equilibrium at 60 °C in 60 min, and 
it was the incubation time we used in the analysis.
The calibration curve was linear over the 
concentration range of 148–3549 ng/l with a 
correlation coefficient of 0.9993. It was not easy to 
obtain linear response over the concentration range. 
Linearity was achieved only at helium pressure of 
139.5 kPa (20 psi), and any decrease (125.6, 111.6, 
and 83.7 kPa) did not yield satisfactory results. The 
flow of helium was as high as 40.3 ml/min, although 
the recommended flow for 0.53 mm I.D. column was 
2.7ml/min. The likely reason for this difference is that 
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we used vapour injection, and the recommended flow 
refers to liquid analysis.
Relative standard deviations (RSD) from benzene 
urine concentrations of 147.9 ng/l (N=9) and 1183.1 
ng/l (N=5) were 2.78% and 3.63%, respectively. The 
detection limit (DL) for benzene was calculated 





 is the standard error of the intercept, b 
is the intercept and m is slope of calibration curve 
y=mx+b. The calculated DL was 42 ng/l. There are 
but a few papers published on benzene determination 
in urine, and they report a different detection limits. 
These differences depend on the technique and 
detector used. Generally, the dynamic headspace 
technique (purge and trap) increases the fraction of 
volatile analytes in the specimen that is injected in 
gas chromatograph decreasing, in turn, the detection 
limit. The detection limit of static headspace and 
PID achieved by Kok and Ong (12) was 40 ng/l. The 
detection limit achieved by Ghittori and co–workers 
(13), who used dynamic headspace and FID 50 ng/l, 
and by Ljungkvist and co–workers (4), who used 
dynamic headspace and mass selective detector, 
was 7 ng/l.
The trueness of the method was obtained by 
analysing the urine samples spiked with the standard 
reference material for benzene. The recovery of the 
five samples with the benzene concentration of 609.5 
ng/l was 71%. The average recoveries achieved for 
dynamic headspace by Ghittori and co–workers 
(13) were in the range of 80–84%, whereas Hung 
and co–workers (14) obtained a 64% recovery.
Benzene was measured in urine of two groups 
of subjects: nonsmokers and smokers (Table 1). It is 
known that benzene in human urine is not the result 
of normal physiological metabolism, and the finding of 
measurable concentrations of benzene in urine reflects 
exposure to this compound. The mean benzene 
urine concentration was 214 (range 61–515 ng/l) in 
nonsmokers and 760 ng/l (range 181–1869 ng/l) in 
smokers. The difference between the two groups was 
statistical significant (t=3.826; P<0.000614). Figure 
2 shows gas chromatograms of the urine samples.
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Figure 2 Chromatograms of A) urine sample from a nonsmoker with 
65 ng/l of benzene, and B) urine sample from a smoker with 760 ng/l 
of benzene
Figure 1 Effect of incubation temperature on the chromatographic peak areas and regression equations at 60 °C (1), 70 °C (2), and 80 °C (3)
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Available literature data on benzene concentrations 
in urine are shown in Table 2. Benzene urine 
concentrations show a wide range in both nonsmokers 
and smokers. Our results for nonsmokers are generally 
higher than the corresponding results in other studies, 
whereas our results for smokers are comparable to 
Ghittori and co–workers (13). The smokers in our 
study smoked more than 25 cigarettes a day, in the 
study of Ghittori and co–workers (13) more than 20, 
and in Kok’s and Ong’s (12) study 90% of the smokers 
smoked less than 20 cigarettes.
We analysed creatinine as a correction for urine 
dilution. However, the equilibration of partial pressures 
in urine and plasma suggests that benzene is eliminated 
from the kidney by diffusion (16). As a result, the 
urine/blood concentration ratio equals the urine/
blood distribution coefficient, and the concentration 
of benzene in urine is independent of urine output. 
Similar benzene concentration ranges in smokers and 
nonsmokers, expressed as ng/l and ng/g creatinine 
in Table 1, show that there is no need for creatinine 
correction of benzene in urine, which is consistent 
with findings published elsewhere (13–16).
Very low benzene concentrations in urine require 
special attention in all steps of specimen handling. 
Namely, benzene is volatile and can easily disappear. 
Furthermore, as it is ubiquitous, it may contaminate 
the sample.
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Sažetak
ODREĐIVANJE BENZENA U URINU PLINSKOKROMATOGRAFSKOM TEHNIKOM ANALIZE 
PARA IZNAD OTOPINE
Opisana je metoda za određivanje benzena u urinu plinskokromatografskom tehnikom analize para iznad 
otopine (“headspace”). Metoda je analitički vrednovana s obzirom na osjetljivost (granica detekcije = 42 
ng/l), ponovljivost (RSD = 3 i 4%) i točnost (71%). Primijenjena je u analizi benzena u urinu nepušača 
(N=14) i pušača (N=18). Benzen je bio mjerljiv u svim uzorcima urina. Dobivena je statistički značajna 
razlika (p<0.000614) između koncentracija benzena u urinu pušača (x=760; raspon=181–1869 ng/l) i 
nepušača (x=214; raspon=61–515 ng/l). Benzen ne dolazi u urin normalnim fiziološkim procesima; u 
nepušača uglavnom potječe iz ispušnih plinova automobila i izgaranja benzina, a u pušača je glavni izvor 
izloženosti benzenu dim cigarete.
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